Edge Asset Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$14.6M Hold
215,349
0.11% 187
2016
Q4
$15.4M Sell
215,349
-3,827
-2% -$284K 0.12% 189
2016
Q3
$17.3M Sell
219,176
-57,642
-21% -$4.68M 0.15% 184
2016
Q2
$23.1M Buy
276,818
+48,050
+21% +$4.26M 0.21% 146
2016
Q1
$21M Buy
228,768
+28,483
+14% +$2.57M 0.2% 144
2015
Q4
$20.3M Buy
200,285
+372
+0.2% +$38.7K 0.2% 136
2015
Q3
$19.6M Sell
199,913
-8,495
-4% -$943K 0.2% 141
2015
Q2
$24.4M Buy
208,408
+24,540
+13% +$2.68M 0.22% 135
2015
Q1
$18M Sell
183,868
-60,300
-25% -$6.12M 0.16% 165
2014
Q4
$23M Sell
244,168
-52,220
-18% -$5.4M 0.22% 119
2014
Q3
$31.6M Sell
296,388
-39,198
-12% -$3.84M 0.32% 88
2014
Q2
$27.8M Sell
335,586
-26,700
-7% -$2.08M 0.28% 94
2014
Q1
$25.7M Sell
362,286
-23,741
-6% -$1.86M 0.27% 97
2013
Q4
$29M Sell
386,027
-29,050
-7% -$2.02M 0.32% 91
2013
Q3
$26.1M Sell
415,077
-39,443
-9% -$2.36M 0.31% 90
2013
Q2
$23.3M Buy
+454,520
New +$23.7M 0.29% 98

Other funds holding GILD

Edge Asset Management's GILD Position: Q1 2017 in Review

Edge Asset Management held its Gilead Sciences (GILD) position steady in Q1 2017 at 215,349 shares worth $14.6M. The position accounts for 0.11% of the portfolio, ranked #187.

Edge Asset Management first reported a position in GILD in Q2 2013 and has held it in 16 quarters since. The position peaked at $31.6M in Q3 2014. 1,526 funds tracked by Wall St. Rank hold GILD as of Q1 2017.

  • Edge Asset Management held 215,349 shares of Gilead Sciences worth $14.6M as of Q1 2017.
  • Edge Asset Management left its Gilead Sciences share count unchanged in Q1 2017.
  • Gilead Sciences made up 0.11% of Edge Asset Management's portfolio in Q1 2017, its #187 holding.
  • Edge Asset Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 16 quarters since.
  • Edge Asset Management's Gilead Sciences position peaked at $31.6M in Q3 2014.
  • 1,526 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2017.

Based on Edge Asset Management's 13F filing for Q1 2017, filed 11 May 2017.